North Star Investment Management’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

North Star Investment Management’s Portfolio AST.WS Stock Details AST.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16	Closed	–	–	1149
2017 Q3	$0	Buy	+16	New	+$5	﹤0.01%	1153

North Star Investment Management's AST.WS Position: Q4 2017 in Review

North Star Investment Management sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q4 2017, closing a stake of 16 shares.

North Star Investment Management first reported a position in AST.WS in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 0 funds tracked by Wall St. Rank hold AST.WS as of Q4 2017.

North Star Investment Management reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q4 2017 after selling out during the quarter.
North Star Investment Management sold 16 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q4 2017.
North Star Investment Management first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q3 2017 and held it in 1 quarter.
North Star Investment Management's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q3 2017.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q4 2017.

Based on North Star Investment Management's 13F filing for Q4 2017, filed 11 Jan 2018.